Display options
Cite
Yang YL, Chen CZ, Jin LP, et al. Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells. Int J Clin Exp Med. 2013;6(10):908-16
Yang, Y. L., Chen, C. Z., Jin, L. P., Ji, Q. Q., Chen, Y. Z., Li, Q., Zhang, X. H., & Qu, J. M. (2013). Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells. International journal of clinical and experimental medicine, 6(10), 908-16.
Yang, Yin-Long, et al. "Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells." International journal of clinical and experimental medicine vol. 6,10 (2013): 908-16.
Yang YL, Chen CZ, Jin LP, Ji QQ, Chen YZ, Li Q, Zhang XH, Qu JM. Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells. Int J Clin Exp Med. 2013 Oct 25;6(10):908-16. eCollection 2013. PMID: 24260596; PMCID: PMC3832327.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2013 Oct 25;6(10):908-16. eCollection 2013.

Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells.

International journal of clinical and experimental medicine

Yin-Long Yang, Cheng-Ze Chen, Lang-Ping Jin, Qian-Qing Ji, Yi-Zuo Chen, Quan Li, Xiao-Hua Zhang, Jin-Miao Qu

Affiliations

  1. Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000, People's Republic of China.

PMID: 24260596 PMCID: PMC3832327

Abstract

OBJECTIVE: To study the effect of the transfected Breast cancer metastasis suppressor 1 (BRMS1) gene on the migration of breast cancer cells and the possible mechanisms involved.

METHODS: MDA-MB-231HM cells which have a high propensity of metastasize to lung was sieved from MDA-MB-231 and its derivative cells stable transfected with BRMS1 were used to study in vitro. Cell migratory ability was observed. The cellular cyclic adenylic acid (cAMP) concentration was tested by radioimmunoassay (RIA). The activity of adenylate cyclase (AC), phosphodiesterase (PDE) and protein kinase A (PKA) were measured by enzyme immunoassay (EIA) and (γ-(32)P) ATP incorporation. The effect of BRMS1 on connexins (Cx) expression was analyzed by by RT-PCR and Western blot.

RESULTS: Overexpression of BRMS1 significantly inhibited cell migration in MDA-MB-231HM cells in vitro. However, BRMS1's effect on cell migration could be eliminated after pretreating with pertussis toxin (PTX). BRMS1 overexpression increased cellular cAMP and PKA activity by activating the activity of AC. Furthermore, BRMS1 overexpression up-regulated Cx26 expression, whereas Cx32, Cx43 expressions did not changed.

CONCLUSION: The present study indicated G-protein-coupled cAMP signaling pathway was involved in BRMS1 related MDA-MB-231HM cells migration, and BRMS1 could change connexins (Cx) expression profiles through increasing expression of Cx26 in cells.

Keywords: BRMS1; Breast cancer; G protein; cAMP; connexin; metastasis; migration

References

  1. J Natl Cancer Inst. 2004 Mar 17;96(6):E4 - PubMed
  2. Front Biosci. 1998 Feb 15;3:d208-36 - PubMed
  3. J Biol Chem. 2002 Aug 9;277(32):29132-8 - PubMed
  4. Cancer Lett. 2008 Sep 28;269(1):46-56 - PubMed
  5. Clin Exp Metastasis. 2000;18(8):683-93 - PubMed
  6. Am Surg. 1995 Dec;61(12):1065-6 - PubMed
  7. Breast Cancer Res. 2007;9(6):R76 - PubMed
  8. J Membr Biol. 2007 Aug;218(1-3):107-21 - PubMed
  9. Cancer Res. 2001 Mar 1;61(5):1765-7 - PubMed
  10. Cancer Res. 2006 Oct 15;66(20):9886-94 - PubMed
  11. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):522-31 - PubMed
  12. Mutat Res. 2001 Jun 2;477(1-2):191-6 - PubMed
  13. Biol Pharm Bull. 2006 Oct;29(10):1991-4 - PubMed
  14. Cancer Res. 2000 Jun 1;60(11):2764-9 - PubMed
  15. Clin Exp Metastasis. 2008;25(3):265-72 - PubMed
  16. Clin Exp Metastasis. 2008;25(7):727-40 - PubMed
  17. Carcinogenesis. 2006 Dec;27(12):2528-37 - PubMed
  18. Exp Cell Res. 2002 Feb 15;273(2):229-39 - PubMed
  19. Cell Growth Differ. 1996 Jul;7(7):861-70 - PubMed
  20. J Biol Chem. 2008 Oct 17;283(42):28354-60 - PubMed
  21. Cancer Res. 2005 Apr 1;65(7):2705-11 - PubMed
  22. Cancer Res. 2005 Feb 1;65(3):713-7 - PubMed
  23. Cancer Sci. 2003 Jun;94(6):501-7 - PubMed

Publication Types